María Cristina Estañ

Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation

Eva Calviño, María Cristina Estañ, Gloria P. Simón et al. · Biochemical Pharmacology · 2011 · 52 citations

Defensive Protein Kinase, Tumor Biology, Hematological Malignancy +11

2-Deoxy-d-glucose cooperates with arsenic trioxide to induce apoptosis in leukemia cells: Involvement of IGF-1R-regulated Akt/mTOR, MEK/ERK and LKB-1/AMPK signaling pathways

María Cristina Estañ, Eva Calviño, Elena de Blas et al. · Biochemical Pharmacology · 2012 · 43 citations · Full text

Hematological Malignancy, Biochemistry, Receptor Tyrosine Kinase +10

Apoptotic Efficacy of Etomoxir in Human Acute Myeloid Leukemia Cells. Cooperation with Arsenic Trioxide and Glycolytic Inhibitors, and Regulation by Oxidative Stress and Protein Kinase Activities

María Cristina Estañ, Eva Calviño, Susana Calvo et al. · PLoS ONE · 2014 · 42 citations · Full text

Recessive mutations in muscle-specific isoforms of FXR1 cause congenital multi-minicore myopathy

María Cristina Estañ, Elisa Fernández-Núñez, Maha S. Zaki et al. · Nature Communications · 2019 · 40 citations · Full text

Regulation of Death Induction and Chemosensitizing Action of 3-Bromopyruvate in Myeloid Leukemia Cells: Energy Depletion, Oxidative Stress, and Protein Kinase Activity Modulation

Eva Calviño, María Cristina Estañ, Carlos Sànchez‐Martìn et al. · Journal of Pharmacology and Experimental Therapeutics · 2013 · 36 citations